The American Journal of Medicine
Volume 119, Issue 9, Supplement 1 , Pages S61-S68 , September 2006

Sex Steroid Hormone Polymorphisms, High-Density Lipoprotein Cholesterol, and Apolipoprotein A-1 from the Study of Women’s Health Across the Nation (SWAN)

References 

  1. Brinton EA . Oral estrogen replacement therapy in postmenopausal women selectively raises levels and production rates of lipoprotein A-I and lowers hepatic lipase activity without lowering the fractional catabolic rate . Arterioscler Thromb Vasc Biol . 1996;16:431–440
  2. de Kleijn MJ , van der Schouw YT , van der Graaf Y . Reproductive history and cardiovascular disease risk in postmenopausal women: a review of the literature . Maturitas . 1999;33:7–36
  3. Solomon CG , Hu FB , Dunaif A , et al.   Menstrual cycle irregularity and risk for future cardiovascular disease . J Clin Endocrinol Metab . 2002;87:2013–2017
  4. Bairey Merz CN , Johnson BD , Sharaf BL , et al.  WISE Study Group   Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: a report from the NHLBI-sponsored WISE study . J Am Coll Cardiol . 2003;41:413–419
  5. Rossouw JE , Anderson GL , Prentice RL , et al.  Writing Group for the Women’s Health Initiative Investigators   Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial . JAMA . 2002;288:321–333
  6. Hulley S , Grady D , Bush T , et al.  Heart and Estrogen/progestin Replacement Study (HERS) Research Group   Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women . JAMA . 1998;280:605–613
  7. Darblade B , Pendaries C , Krust A , et al.   Estradiol alters nitric oxide production in the mouse aorta through the α-, but not β-, estrogen receptor . Circ Res . 2002;90:413–419
  8. Lubahn DB , Moyer JS , Golding TS , Couse JF , Korach KS , Smithies O . Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene . Proc Natl Acad Sci U S A . 1993;90:11162–11166
  9. Couse JF , Curtis SW , Washburn TF , et al.   Analysis of transcription and estrogen insensitivity in the female mouse after targeted disruption of the estrogen receptor gene . Mol Endocrinol . 1995;9:1441–1454
  10. Pendaries C , Darblade B , Rochaix P , et al.   The AF-1 activation-function of ERα may be dispensable to mediate the effect of estradiol on endothelial NO production in mice . Proc Natl Acad Sci U S A . 2002;99:2205–2210
  11. Hodgin JB , Krege JH , Reddick RL , Korach KS , Smithies O , Maeda N . Estrogen receptor α is a major mediator of 17β-estradiol’s atheroprotective effects on lesion size in Apoe–/– mice . J Clin Invest . 2001;107:333–340
  12. Almeida S , Franken N , Zandoná MR , Osória-Wender MC , Hutz MH . Estrogen receptor 2 and progesterone receptor gene polymorphisms and lipid levels in women with different hormonal status . Pharmacogenomics J . 2005;5:30–34
  13. Mahaney MC , Blangero J , Comuzzie AG , VandeBerg JL , Stern MP , MacCluer JW . Plasma HDL cholesterol, triglycerides, and adiposity: a quantitative genetic test of the conjoint trait hypothesis in the San Antonio Family Heart Study . Circulation . 1995;92:3240–3248
  14. Austin MA , Talmud PJ , Luong LA , et al.   Candidate-gene studies of the atherogenic lipoprotein phenotype: a sib-pair linkage analysis of DZ women twins . Am J Hum Genet . 1998;62:406–419
  15. Xu JF , Prenger VL , Coresh J , Beaty TH . Two-locus and bivariate segregation analysis of HDL-C and apo AI . Genet Epidemiol . 1993;10:605–610
  16. Herrington DM , Howard TD , Hawkins GA , et al.   Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease . N Engl J Med . 2002;346:967–974
  17. Manninen V , Tenkanen L , Koskinen P . Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study . Circulation . 1992;85:37–45
  18. Gordon T , Castelli WP , Hjortland MC , Kannel WB , Dawber TR . High density lipoprotein as a protective factor against coronary heart disease: the Framingham Study . Am J Med . 1977;62:707–714
  19. Sowers MF , Crawford S , Sternfeld B , et al.   Design, survey sampling and recruitment methods of SWAN: a multicenter, multiethnic, community-based cohort study of women and the menopausal transition . In:  Lobo RA ,  Kelsey J ,  Marcus R editor. Menopause: Biology and Pathobiology . San Diego, CA: Academic Press; 2000;p. 175–188
  20. Kardia SR , Chu J , Sowers MF . Characterizing variation in sex steroid hormone pathway genes in women of 4 races/ethnicities: the Study of Women’s Health Across the Nation (SWAN) . Am J Med . 2006;119(suppl 9A):S3–S15
  21. Single Nucleotide Polymorphism database: dbSNP search page. National Center for Biotechnology Information Web site. Available at: http://www.ncbi.nlm.nih.gov/SNP/. Accessed September 25, 2005.
  22. Steiner P , Freidel J , Bremner W , Stein E . Standardization of micromethods for plasma cholesterol, triglyceride and HDL-cholesterol with the lipid clinics’ methodology [abstract] . J Clin Chem . 1981;19:850
  23. Warnick GR , Albers JJ . A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high-density lipoprotein cholesterol . J Lipid Res . 1978;19:65–76
  24. Myers GL , Cooper GR , Winn CL , Smith SJ . The Centers for Disease Control–National Heart, Lung, and Blood Institute Lipid Standardization Program: an approach to accurate and precise lipid measurements . Clin Lab Med . 1989;9:105–135
  25. Ferris B . Epidemiology Standardization Project (American Thoracic Society) . Am Rev Respir Dis . 1978;118:1–120
  26. Baecke JA , Burema J , Fritjers JE . A short questionnaire for the measurement of habitual physical activity in epidemiological studies . Am J Clin Nutr . 1982;36:936–942
  27. Sternfeld B , Ainsworth BE , Quesenberry CP . Physical activity patterns in a diverse population of women . Prev Med . 1999;28:313–323
  28. Matthews KA , Sowers MF , Derby CA , et al.   Ethnic differences in cardiovascular risk factor burden among middle-aged women: Study of Women’s Health Across the Nation (SWAN) . Am Heart J . 2005;149:1066–1073
  29. Beer DG , Kardia SLR , Huang C-C , et al.   Gene-expression profiles predict survival of patients with lung adenocarcinoma . Nat Med . 2002;8:816–824
  30. R Development Core Team . R: A Language and Environment for Statistical Computing . Vienna, Austria: R Foundation for Statistical Computing; 2005;
  31. Dean BB , Borenstein JE , Henning JM , Knight K , Bairey Merz CN . Can change in high-density lipoprotein cholesterol levels reduce cardiovascular risk? . Am Heart J . 2004;147:966–976
  32. Losordo DW , Kearney M , Kim EA , Jekanowski J , Isner JM . Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women . Circulation . 1994;89:1501–1510
  33. Karas RH , Patterson BL , Mendelsohn ME . Human vascular smooth muscle cells contain functional estrogen receptor . Circulation . 1994;89:1943–1950
  34. Venkov CD , Rankin AB , Vaughan DE . Identification of authentic estrogen receptor in cultured endothelial cells: a potential mechanism for steroid hormone regulation of endothelial function . Circulation . 1996;94:727–733
  35. Grohé C , Kahlert S , Löbbert K , et al.   Cardiac myocytes and fibroblasts contain functional estrogen receptors . FEBS Lett . 1997;416:107–112
  36. Sudhir K , Chou TM , Chatterjee K , et al.   Premature coronary artery disease associated with a disruptive mutation in the estrogen receptor gene in a man . Circulation . 1997;96:3774–3777
  37. Smith EP , Boyd J , Frank GR , et al.   Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man . N Engl J Med . 1994;331:1056–1061
  38. Hodges YK , Richer JK , Horwitz KB , Horwitz LD . Variant estrogen and progesterone receptor messages in human vascular smooth muscle . Circulation . 1999;99:2688–2693
  39. Schuit SCE , Oei HHS , Witteman JCM , et al.   Estrogen receptor α gene polymorphisms and risk of myocardial infarction . JAMA . 2004;291:2969–2977
  40. Herrington DM , Howard TD , Brosnihan KB , et al.   Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein . Circulation . 2002;105:1879–1882
  41. Koivu TA , Fan YM , Mattila KM , et al.   The effect of hormone replacement therapy on atherosclerotic severity in relation to ESR1 genotype in postmenopausal women . Maturitas . 2003;44:29–38
  42. Matsubara Y , Murata M , Kawano K , et al.   Genotype distribution of estrogen receptor polymorphisms in men and postmenopausal women from healthy and coronary populations and its relation to serum lipid levels . Arterioscler Thromb Vasc Biol . 1997;17:3006–3012
  43. Ruaño G , Seip RL , Windemuth A , et al.   Apolipoprotein A1 genotype affects the change in high density lipoprotein cholesterol subfractions with exercise training . Atherosclerosis . 2006;185:65–69

 The Study of Women’s Health Across the Nation (SWAN) and the SWAN Repository were supported by grants from the National Institutes of Health (NIH), Department of Health and Human Services, through the National Institute on Aging, the National Institute of Nursing Research, and the NIH Office of Research on Women’s Health (Grant Nos. AG017719, NR004061, AG012505, AG012535, AG012531, AG012539, AG012546, AG012553, AG012554, and AG012495). The Sex Steroid Hormone Genetics Protocol was supported by the SWAN Repository.This report is based on samples from the SWAN DNA Repository. Scientists interested in developing studies based on this resource, can find a description of the SWAN Core Repository and SWAN DNA Repository and information on obtaining access to the resources at www.swanrepository.org.

PII: S0002-9343(06)00830-8

doi: 10.1016/j.amjmed.2006.07.008

The American Journal of Medicine
Volume 119, Issue 9, Supplement 1 , Pages S61-S68 , September 2006

Article Tools